Cost Reduction in Cell and Gene Therapy 2023: Featuring Key Players Roche, Bayer and Novartis, as well as Start-Ups Dyno Therapeutics and Capsigen
/PRNewswire/ -- The "Cost Reduction in Cell and Gene Therapy" report has been added to ResearchAndMarkets.com's offering. With the advancement of delivery...
Source: prnewswire.com